Company Description

Perturba is an AI-native therapeutics company accelerating drug discovery through systems-level understanding of diseases. By combining scalable in vivo CRISPR perturbation with AI, PerturbAI maps biological circuits directly inside intact organisms, enabling a new generation of therapeutics grounded in causal, in vivo biology.